✉news BusinessStartups first seen 18 h ago, last 14 h ago, peak #12
New $600 Million Fund to Revive Stalled Drugs With AI
Original: This New $600 Million Fund Will Supercharge Stalled Drugs With AI
A new $600 million fund has been launched to apply artificial intelligence to stalled drug development, aiming to rescue promising medicines that failed to advance through conventional means. The fund was reported by Forbes and targets biotech pipelines where AI could identify new uses or paths forward for shelved compounds. It signals growing investor confidence that AI can cut pharmaceutical R&D costs and timelines.
Why now: Investors and biotech watchers are focusing on AI as a way to revive expensive, stalled drug programs.
$600 million AI drug fundForbes
Rank over time, top of the chart is #1. 4 snapshots from 18 h ago to 14 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/3999189